Question Number: 238
PDR Number: SQ22-000608
Date Submitted: 21/11/2022
Department or Body: Department of Health
The redacted sections in the nonclinical evaluation report for BNT162b2 [mRNA] COVID-19 vaccine (COMIRANTY™) January 2021, include: aspects of the specific assay methods; details of mRNA variants in development; details associated with product formulation and specifications; and/or details associated with the manufacturing processes for BNT162 vaccine variants used in the nonclinical studies. These redacted sections are considered to contain commercially valuable information.